Sulprostone

DB12708InvestigationalSmall molecule

Sulprostone is a prostaglandin analogue used to treat post-partum hemorrhaging, induce medical abortion, and induce labour in instances of in utero fetal death. Sulprostone has been used in trials studying Abortion, Induced.

Mechanism: Pharmacologically active on Prostaglandin E2 receptor EP1 subtype and Prostaglandin E2 receptor EP3 subtype
Curator reviewed
Formula / weight: C₂₃H₃₁NO₇S · 465.56 g/mol (avg)
Code names: CP-34,089 · ZK-57671

Resolves to

Compound

UNII501Q5EQ1GMCAS60325-46-4ChEMBLCHEMBL1472830ChEBI135755PubChem5312153

Clinical / RWD

ATCG02AD05

Structure

InChIKeyUQZVCDCIMBLVNR-TWYODKAFSA-NSMILESCS(=O)(=O)NC(=O)CCC\C=C/C[C@@H]1[C@@H](\C=C\[C@@H](O)COC2=CC=CC=C2)[C@H](O)CC1=O

Targets

P34995PTGER1P43115PTGER3

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Drug interactionStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

6Structured indicationsCondition, population, route and combination as fields, not prose

20ContraindicationsEach with its own population and attribute set

4Marketed productsAcross 3 countries and 3 labellers

1ATC codeIncluding every combination product, plus 16 drug categories

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Sulprostone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In